|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues: | |||||
| Revenues | |||||
| Cost of revenues | |||||
| Net revenues | |||||
| Operating expenses: | |||||
| Research and development | |||||
| General and administrative | |||||
| Reserve for credit losses | |||||
| Legal expenses | |||||
| Reserve for credit losses and other expenses | |||||
| Legal expenses (recoveries), net | |||||
| Impairment of Long-Lived Asset | |||||
| Nonoperating loss | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Interest expense | |||||
| Change in fair value of investment | |||||
| Change in fair value of contingent liability | |||||
| Loss on sale of put shares | |||||
| Gain on extinguishment of liability | |||||
| Other income, net | |||||
| Net loss | |||||
| Equity dividend to investor | |||||
| Net loss attributable to Common Stockholders | |||||
| Net loss per share, basic | |||||
| Net loss per share, diluted | |||||
| Weighted-average shares outstanding, basic | |||||
| Weighted-average shares outstanding, diluted | |||||
Loading...